APA (7th ed.) Citation

CAM, T., PO, G., M, F., K, S., GFA, P., FMT, B., . . . PA, L. (2025). Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: A landmark analysis from the NEOMINDSET trial. European heart journal. https://doi.org/10.1093/eurheartj/ehaf1050

Chicago Style (17th ed.) Citation

CAM, Tavares, et al. "Prasugrel or Ticagrelor Monotherapy Vs Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Landmark Analysis from the NEOMINDSET Trial." European Heart Journal 2025. https://doi.org/10.1093/eurheartj/ehaf1050.

MLA (9th ed.) Citation

CAM, Tavares, et al. "Prasugrel or Ticagrelor Monotherapy Vs Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Landmark Analysis from the NEOMINDSET Trial." European Heart Journal, 2025, https://doi.org/10.1093/eurheartj/ehaf1050.